RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Genetica Bioscience

Genetica Bioscience

Genetica Bioscience specializes in biotechnology, offering biorremediators, bioestimuladores, and water analysis services.

Latest funding

Series B+ ·

Amount not disclosed in a source on record.

Funding history ↓

Acquired by AArchiMed on · ARCHIMED.

LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biopharma, Biotechnology, Test and Measurement.
Stage: Series B+.
Based in: Chapecó, Brazil.
Last round: Oct 14, 2026 · 9 days ago.
Domain age: 12 years.
On Recent Funding since: Oct 16, 2026.
About Genetica Bioscience

Genetica Bioscience is a company based in Chapecó, Brazil. Recent Funding lists it under Health and bio. Its latest known round is a Series B+ round (October 2026); no sourced amount is on record for it yet. Investors on record for it include Rise. It was acquired by ArchiMed in October 2026.

Funding rounds

  1. Series B+ · amount undisclosed
  2. Acquired by AArchiMed
    Source: ARCHIMED
  3. Website created

Investors

Similar Health and bio companies

Questions and sources

Genetica Bioscience: questions and answers

Who invested in Genetica Bioscience?
Investors on record for Genetica Bioscience: Rise.
Where is Genetica Bioscience based?
Genetica Bioscience is based in Chapecó, Brazil.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/genetica-bioscience (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy